Publications

Publications

Filter Results: (470) Arrow Down
Filter Results: (470) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 3 of 470 Results →
  • September–October 2020
  • Article

The Past, Present, and (Near) Future of Gene Therapy and Gene Editing

By: Julia Pian, Amitabh Chandra and Ariel Dora Stern
Emerging gene therapy and gene-editing technologies will have a growing impact on patient lives and health-care delivery. We analyzed a decade of data on clinical trials and venture capital investments to understand the likely trajectory of genetically focused... View Details
Keywords: Gene Therapy; Gene Editing; Impact; Health Care and Treatment; Technological Innovation; Health Testing and Trials; Venture Capital; Change
Related
  • 15 Nov 2017
  • HBS Seminar

William Mann, UCLA Anderson

    Sophus A. Reinert

    Sophus Reinert is T.J. Dermot Dunphy Professor of Business Administration and of History in the Business, Government, and the International Economy Unit at Harvard Business School and in the History Department and Harvard University. He has won numerous awards... View Details

    Keywords: banking; defense; education industry; fashion; food; manufacturing; wine
    • May 2009 (Revised August 2013)
    • Case

    The DiagnoFirst Opportunity

    By: Robert C. Pozen and Rukmini Balu
    John Mason, a principle at Oldwell Partners, was facing a decision of whether or not to invest in DiagnoFirst, a molecular diagnostics firm. DiagnoFirst's key product was a genetic test that identified a subset of prostate cancer patients with a high risk of clinical... View Details
    Keywords: Genetic Engineering; Genetically Modified; Genomics; Venture Capital; Patents; Genetics; Decision Choices and Conditions; Laws and Statutes; Investment; Science-Based Business; Biotechnology Industry
    Related
    • May 2009 (Revised June 2011)
    • Case

    Going to the Oracle: Goldman Sachs, September 2008

    By: Clayton S. Rose and David Lane
    On September 23, 2008, in the midst of an historic crisis in the U.S. financial markets, Warren Buffet's Berkshire Hathaway invested $5 billion in Goldman Sachs. Goldman CEO, Lloyd Blankfein, said: "We are pleased that given our longstanding relationship, Warren... View Details
    Keywords: Decision Choices and Conditions; Financial Crisis; Capital Structure; Financial Liquidity; Financial Markets; Investment; Performance Capacity; Financial Services Industry; United States
    Related
    • 29 Oct 2014
    • Research & Ideas

    Inventing Products is Less Valuable Than Inventing Ideas

    competitors in a certain area from capitalizing on the R&D infrastructure you set up. Ahuja also advises creating moderately sized research teams; not too large that they become bureaucratic and unproductive, but not too small that... View Details
    Keywords: by Michael Blanding; Technology
    • 29 Aug 2014
    • Working Paper Summaries

    Patent Trolls

    Keywords: by Lauren Cohen, Umit G. Gurun & Scott Duke Kominers
    • May 2006 (Revised June 2006)
    • Case

    Codon Devices

    By: Joseph B. Lassiter III and David Kiron
    In December 2005, 40-year-old John Danner was about to make his first presentation to the board of directors of Codon Devices, a one-year-old biotechnology start-up based in Cambridge, Massachusetts. After a month as the company's CEO, Danner was prepared to lay out... View Details
    Keywords: Strategic Planning; Venture Capital; Intellectual Property; Governing and Advisory Boards; Genetics; Competitive Advantage; Science-Based Business; Business Startups; Growth and Development Strategy; Biotechnology Industry; Cambridge
    Related
    • March 2011 (Revised April 2018)
    • Case

    1366 Technologies: Scaling the Venture

    By: Joseph B. Lassiter III, Ramana Nanda, David Kiron and Evan Richardson
    For some time, 1366's co-founders, Frank van Mierlo and Ely Sachs, had faced a choice, which was now made all the more stark: 1366 could expand to produce silicon wafers itself, raising the required capital from "friendly" investors and building shipment volume slowly,... View Details
    Keywords: Information Technology; Innovation Strategy; Corporate Strategy; Intellectual Property; Management Teams; Renewable Energy; Financial Strategy; Growth and Development Strategy; Corporate Finance; Energy Industry; Technology Industry; United States
    Related
    • 27 Mar 2007
    • First Look

    First Look: March 27, 2007

    company. They can either sell the company to a large public company, raise another round of capital from a preeminent venture capital fund, or continue to grow using existing positive cash flow. Purchase... View Details
    Keywords: Martha Lagace
    • October 1995 (Revised March 1996)
    • Case

    Booz.Allen & Hamilton: Vision 2000

    In 1993, Booz.Allen & Hamilton forsook its previous, highly local organizational structure. It was motivated by a desire to serve multinational clients more effectively and to provide greater value to clients with more localized business by collecting best practices... View Details
    Keywords: Organizational Change and Adaptation; Service Operations; Service Delivery; Organizational Structure; Global Strategy; Service Industry
    Related
    • 14 Aug 2012
    • First Look

    First Look: August 14

    http://www.hbs.edu/research/pdf/13-010.pdf IP Modularity: Profiting from Innovation by Aligning Product Architecture with Intellectual Property Authors:Joachim Henkel, Carliss Y. Baldwin, and Willy C. Shih Abstract Distributed value... View Details
    Keywords: Sean Silverthorne

      Tom Nicholas

      Tom Nicholas is William J. Abernathy Professor of Business Administration at Harvard Business School. He is British and holds a doctorate from Oxford University. His research focuses on the history of entrepreneurship, innovation and finance. His book (VC: An... View Details

      Keywords: financial services; high technology
      • 10 Jan 2017
      • First Look

      First Look at New Research: January 10, 2017

      alter the underlying setup, and a “final no.” Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=52029 Disruptive Innovation: Intellectual History and Future Paths By: Christensen, Clayton M., Rory McDonald, Elizabeth J.... View Details
      Keywords: Sean Silverthorne
      • 23 May 2012
      • Research & Ideas

      Five Ways to Make Your Company More Innovative

      In a hypercompetitive global economy, creativity has never been more important for success . But how do you create a company that unleashes and capitalizes on innovation? For answers, writers at the HBS Alumni Bulletin turned to five HBS... View Details
      Keywords: by Garry Emmons, Julia Hanna & Roger Thompson
      • 03 Apr 2008
      • Working Paper Summaries

      Bridge Building in Venture Capital-Backed Acquisitions

      Keywords: by Paul A. Gompers & Yuhai Xuan
      • 13 Nov 2006
      • Research & Ideas

      Science Business: What Happened to Biotech?

      describe it, has worked well for certain things in the industry, but not so well for others. What are some of the attributes of the anatomy and how has it contributed to performance shortfall? A: Let's take one: the market for know-how. I argue in the book that... View Details
      Keywords: by Sean Silverthorne; Biotechnology

        Christopher A. Bartlett

        Professor Christopher A. Bartlett received an economics degree from the University of Queensland, Australia (1964), and both the masters and doctorate degrees in business administration from Harvard University (1971 and 1979). 

        As a practicing manager prior... View Details

        Keywords: consulting; health care; management consulting; manufacturing; medical supplies; wine
        • 14 Aug 2023
        • Blog Post

        Crossing the Bridge: A Reflection on the HKS/HBS Joint Degree Program

        Association which has provided me access to Harvard leadership and insight to capital planning and university affairs. Just one of these individual experiences alone could be considered life-changing, and consequently I feel my life... View Details
        • September 2020
        • Case

        Minerva 2004: Discovery

        By: John R. Wells and Benjamin Weinstock
        After nearly five years in operation, Doctor Cynthia Bamdad, founder and CEO of Minerva Biotechnologies Corporation (Minerva), was reflecting on the company’s next steps. In a few short years, she and her small team had managed to develop a nanoparticle process for... View Details
        Keywords: Entrepreneurship; Financing and Loans; Strategy; Decision Choices and Conditions; Biotechnology Industry
        Related